Eli Lilly And Co vs Wells Fargo & Co — how do they compare? Eli Lilly And Co trades at $1,214.54 (market cap $1.08T), while Wells Fargo & Co trades at $87.35 (market cap $264.66B). The key difference: Eli Lilly And Co is far larger — about 4.1× Wells Fargo & Co's market cap, and Wells Fargo & Co pays the higher dividend (2.29%). Which is the better fit depends on your goals.
| LLY | WFC | |
|---|---|---|
Market Cap | $1.08T | $264.66B |
Sector | Health | Financials |
52-Week High | $1.24K | $96.40 |
52-Week Low | $639.43 | $73.42 |
Enterprise Value | $1.13T | — |
Dividend Yield | 0.57% | 2.29% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Wells Fargo (WFC) trades at $87.55, up 0.34% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals, including a P/E of 12.72, net income margin of 25.97%, and ROE of 13.13%. Recent earnings beat expectations in Q2 2026, and the company is expanding digital services like tokenized deposits. Analyst consensus is mixed but leans positive, with a price target of $97.64.
The outlook for WFC is favorable, driven by earnings growth and strategic innovations, though risks include volatile cash flows and economic sensitivity. Upside potential exists if the company meets future earnings and maintains profitability, but investors should monitor execution and macroeconomic factors.
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →